Becker's Healthcare November 28, 2022
Noah Schwartz

Bionaut Labs, a company that makes micro-robotics used in the treatment of central nervous system diseases, has raised $43 million in series B financing.

Bionaut’s robots work to deliver drugs at deep levels in the midbrain. The company will use this financing to advance its clinical trials of treatment programs for malignant glioma brain tumors and Dandy-Walker Syndrome, according to a Nov. 28 Bionaut news release.

Khosla Ventures...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Robotics/RPA, Technology, Trends
Less pain, quicker recoveries: 1 year of University Hospitals' robotics push
Here’s The Second Humanoid Robot To Get A Paying Job
CES 2025: 20 Tech Experts Predict Highlights And Trends
Study explores factors influencing acceptance of home-care robots
FHC #157: NVIDIA expects AI, robots to cure healthcare’s biggest problems

Share This Article